| |
| |
|
| Insider
Information: |
Yea Christopher |
| Relationship: |
|
| City: |
Salisbury, Wiltshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
72,895 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$868,908 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
72,895 |
|
|
| Total
Value |
$868,908 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.7
|
| Percentage
Gain/Loss : |
0.0%
|
 157.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-02-20 |
72,895 |
2016-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2016-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
82,969 |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-22 |
4 |
OE |
$0.00 |
$6 |
D/D |
1,302 |
84,271 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-22 |
4 |
AS |
$17.00 |
$22,139 |
D/D |
(1,302) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-23 |
4 |
OE |
$0.00 |
$3 |
D/D |
600 |
83,569 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-23 |
4 |
AS |
$17.01 |
$10,205 |
D/D |
(600) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-25 |
4 |
AS |
$17.06 |
$93,015 |
D/D |
(5,453) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-01-25 |
4 |
OE |
$0.00 |
$23 |
D/D |
5,453 |
88,422 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-04-22 |
4 |
OE |
$0.00 |
$32 |
D/D |
7,355 |
90,324 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-04-22 |
4 |
AS |
$25.92 |
$191,530 |
D/D |
(7,355) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-07-22 |
4 |
OE |
$0.00 |
$32 |
D/D |
7,355 |
90,324 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-07-22 |
4 |
AS |
$18.35 |
$134,930 |
D/D |
(7,355) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-12 |
4 |
AS |
$17.00 |
$3,383 |
D/D |
(199) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-12 |
4 |
OE |
$0.00 |
$1 |
D/D |
199 |
83,168 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-13 |
4 |
OE |
$0.00 |
$6 |
D/D |
1,500 |
84,469 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-13 |
4 |
AS |
$17.05 |
$25,568 |
D/D |
(1,500) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$13 |
D/D |
3,010 |
85,979 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
AS |
$17.05 |
$51,318 |
D/D |
(3,010) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-20 |
4 |
AS |
$17.02 |
$45,025 |
D/D |
(2,646) |
82,969 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2019-12-20 |
4 |
OE |
$0.00 |
$11 |
D/D |
2,646 |
85,615 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2020-02-05 |
4 |
AS |
$17.10 |
$1,710 |
D/D |
(100) |
82,869 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2020-10-16 |
4 |
AS |
$17.00 |
$15,539 |
D/D |
(914) |
81,955 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2020-10-20 |
4 |
AS |
$17.27 |
$138,886 |
D/D |
(7,942) |
74,013 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2020-10-21 |
4 |
AS |
$17.68 |
$110,282 |
D/D |
(6,044) |
67,969 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2020-10-29 |
4 |
AS |
$17.48 |
$87,394 |
D/D |
(5,000) |
62,969 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Development Officer |
• – – |
2021-02-23 |
4 |
AS |
$31.87 |
$503,877 |
D/D |
(15,000) |
47,969 |
0 |
% |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
